Affimed to Present at the Jefferies 2019 Healthcare Conference
May 29 2019 - 5:00AM
Heidelberg, Germany, May 29, 2019 - Affimed N.V.
(Nasdaq: AFMD), a clinical stage biopharmaceutical company
committed to giving patients back their innate ability to fight
cancer, today announced that its Chief Executive Officer, Dr. Adi
Hoess, will present at the Jefferies 2019 Healthcare Conference on
Wednesday, June 5, 2019 at 10:00 a.m. Eastern Time.
A live webcast of the presentation can be
accessed under the “News & Events” section of Affimed’s website
at http://www.affimed.com/news-events/ and will be available for 30
days following the event.
About Affimed N.V.
Affimed (Nasdaq: AFMD) is a clinical stage
biopharmaceutical company committed to giving patients back their
innate ability to fight cancer. Affimed’s fit-for-purpose ROCK®
platform allows innate immune engagers to be designed for specific
patient populations. The Company is developing single and
combination therapies to treat cancers. For more information,
please visit www.affimed.com.
Affimed Investor
Contact:Gregory Gin, Head of Investor RelationsE-Mail:
IR@affimed.com
Affimed Media Contact:Anca
Alexandru, Head of Communications, EU IRE-Mail:
media@affimed.com
Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
From Sep 2023 to Sep 2024